Lundstrom
Lundstrom v. Young
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 BRIAN LUNDSTROM, Case No.: 18-cv-2856-GPC
Plaintiff,
ORDER GRANTING LIGAND’S
v. MOTION FOR LEAVE TO AMEND
ANSWER AND DEFENSES TO
CARLA YOUNG, an individual;
SECOND AMENDED COMPLAINT
LIGAND PHARMACEUTICALS, INC.;
LIGAND PHARMACEUTICALS, INC.
[ECF No. 146] 401(K) PLAN; and DOES 1 through 20, Defendant. 18 On February 23, 2023, Defendants Ligand Pharmaceuticals and Ligand Pharmaceuticals, Inc. 401(k) Plan (“Defendants” or collectively “Ligand”) filed a Motion for Leave to Amend Answer and Defenses to the Second Amended Complaint. ECF No. 146. The Court set a briefing schedule. ECF No. 147. On March 17, 2023, Plaintiff Brian Lundstrom (“Plaintiff” or “Lundstrom”) filed a Non-Opposition. ECF No. 153. A party seeking to amend a pleading past a scheduling order deadline must show “good cause” for such relief. Fed. R. Civ. P. 16(b)(4). A court should grant leave to amend a pleading…